Carlos Santana, Chris Perez

Running down the rosters: Cleveland Indians

6 Comments

Even after giving up their top two pitching prospects for Ubaldo Jimenez, the Indians couldn’t maintain their hot start last year and lost their last four games to finish under .500 at 80-82. The offseason saw them shopping from the scrap heap, which isn’t unusual, but even as they were forced to pick from largely unwanted players, they did well with what they had. Unfortunately for them, they couldn’t answer when the team that finished 15 games ahead of them last year added Prince Fielder.

Rotation
Ubaldo Jimenez – R
Justin Masterson – R
Derek Lowe – R
Josh Tomlin – R
Kevin Slowey – R

Bullpen
Chris Perez – R
Vinnie Pestano – R
Tony Sipp – L
Joe Smith – R
Rafael Perez – L
Dan Wheeler – R
Frank Herrmann – R

Disabled list: Carlos Carrasco (R)
Restricted list: ex-Fausto Carmona (R)
SP next in line: David Huff (L), Jeanmar Gomez (R), Zach McAllister (R)
RP next in line: Nick Hagadone (L), Chris Ray (R), Jeremy Accardo (R), Robinson Tejeda (R)

The addition of Lowe from Atlanta was supposed to give the Indians the most groundball-focused rotation the league has seen in years. The Fausto Carmona situation, however, has taken some of the wind out of those sails, especially since it looks like he’ll be replaced by Slowey, one of the league’s top flyball pitchers. I don’t necessarily think that’s a downgrade, though. In fact, I’m not sure the Indians’ original strategy was such a good idea; they play in a pitcher’s park and their outfield defense figures to be quite a bit better than their infield defense.

The bullpen has two openings, with Herrmann and Hagadone competing against a host of veterans on minor league deals. I’m nervous about Perez in the closer’s role — his velocity is down a bit and his strikeout rate took a big tumble last year — but Pestano rates as maybe the game’s best reliever no one knows about. He can step in if Perez struggles.

Lineup
CF Grady Sizemore – L
SS Asdrubal Cabrera – S
RF Shin-Soo Choo – L
C Carlos Santana – S
DH Travis Hafner – L
2B Jason Kipnis – L
1B Casey Kotchman – L
3B Jack Hannahan – L
LF Michael Brantley – L

Bench
C Lou Marson – R
INF Jason Donald – R
1B/OF Shelley Duncan – R
OF Ryan Spilborghs – R

Next in line: C Matt Pagnozzi (R), 1B Matt LaPorta (R), 1B-3B Russ Canzler (R), 2B Cord Phelps (S), 2B-3B Jose Lopez (R), 3B Lonnie Chisenhall (L), 3B Andy LaRoche (L),
OF Aaron Cunningham (R), OF Ezequiel Carrera (L), OF Felix Pie (L), OF Fred Lewis (L), OF Trevor Crowe (S)

And then there’s the lineup. After re-signing Sizemore and bringing in Kotchman to start over LaPorta, the Indians will be able to go with nine left-handed hitters against right-handed pitching. Of course, things will get dicey against lefties. I think Cleveland might have been better off moving Brantley to center and adding a right-handed bat in Sizemore’s place.

That said, the Indians do deserve a ton of credit for bringing in the winter’s greatest haul in minor league free agency. That “next in line” group is probably the strongest any team can boast, and it gives the Indians plenty of bench options.

My controversial call above is sticking Chisenhall back in the minors. I didn’t want to do it, but the bench works much better that way. A right-handed-hitting backup infielder is a must, whether it’s Donald or Lopez. Hannahan, as a lefty, would be pretty useless as a reserve, but the Indians appear unlikely to cut him after re-upping him for $1.35 million last month. My preference would be for a Hannahan trade, leaving Chisenhall as the starter at third.

The Indians’ chances in 2012 figure to hinge on return to forms from Sizemore, Choo and Jimenez. If two of the three former All-Stars contend for a return to this year’s Midsummer Classic, then the Indians should be capable of winning 90 games and hanging in the playoff race.

Marlins acquire starter Dan Straily from the Reds

CINCINNATI, OH - SEPTEMBER 3: Dan Straily #58 of the Cincinnati Reds throws a pitch during the first inning of the game against the St. Louis Cardinals at Great American Ball Park on September 3, 2016 in Cincinnati, Ohio. (Photo by John Sommers II/Getty Images)
Getty Images
1 Comment

The Miami Marlins have acquired starting pitcher Dan Straily from the Cincinnati Reds. In exchange, the Reds will receive right-handed pitching prospects Luis Castillo and Austin Brice and outfield prospect Isaiah White.

For the Marlins, they get a solid starter who logged 191.1 innings of 113 ERA+ ball last year. Straily has moved around a lot in his five big league seasons — the Marlins will be his fifth club in six years — but it was something of a breakout year for him in Cincinnati. The only troubling thing: he tied for the league lead in homers allowed. Of course, pitching half of his games in Great American Ballpark didn’t help that, and Miami will be a better place for him.

Castillo is 24. He split last season between high-A and Double-A — far more of it in A-ball — posting a 2.26 ERA over 24 starts. Austin Brice is also 24. He pitched 15 games in relief for the Marlins last year at the big league level with poor results. He seemed to blossom at Triple-A, however, after the Marlins shifted him to the pen. White was a third round pick in the 2015 draft. He played low-A ball as a minor leaguer last year, hitting .214/.306/.301.

A mixed bag of young talent for the Reds, but stockpiling kids and seeing what shakes out is what a team like the Reds should be doing at the moment. For the Marlins: a solid mid-to-back end starter who may just be coming into his own.

Have Hall of Fame Voters actually made the PED thing More complicated?

Sammy Sosa
Associated Press
26 Comments

The story coming out of this year’s Hall of Fame balloting is that the BBWAA voters are finally easing their antipathy toward players with performance enhancing drug associations.

Jeff Bagwell — the subject of unconfirmed PED rumors — made the Hall! Pudge Rodriguez, who was named in Jose Canseco’s book and who had a . . . curious physical transformation around the time PED testing came online, made it on the first ballot! Barry Bonds and Roger Clemens, whose PED use was well-documented, saw their vote totals advance above the 50% mark, making their future elections look more likely!

It’s an interesting development, and one I’m obviously pleased with, but I wonder if the BBWAA’s new approach to PED guys, while far more forgiving than it used to be, has actually become more complicated in practice.

I ask this because I look way, way down the ballot and I still see Sammy Sosa scraping by with around 8% of the vote. I ask this because I still see Gary Sheffield at 13%. I ask this because when Mark McGwire was on the Today’s Game ballot in December, no one really stumped for him at all. I ask this because, even though Bagwell and Mike Piazza got in eventually, they still had to go through a lot of hazing first and I suspect, if they hit the ballot for the first time again tomorrow, the same arguments and delay would occur with respect to their cases.

In light of that, what I suspect has happened has not been a wholesale surrender of the anti-PED voters. Rather, I think it has been a transformation. One in which a moral test — did he use PEDs or not? — has been discarded as a threshold question and a scientific/physiological test — would he have been great even without the PEDs? — has replaced it. In essence, voters are becoming “PED discounters” in the aggregate. Making calculations as to whether a guy was, in their mind, a creation of PEDs or not.

Such an approach explains these new voting patterns as well as those in recent years.

  • Ivan Rodriguez may have been called out by Canseco and may have noticeably shrunk over an offseason, but his calling card was his defense behind the plate and voters, I suspect, have told themselves that such a thing is not PED-aided.
  • Bonds and Clemens may have been PED users, but each of them was undeniably talented and, if you discount for the PED use, hey, they’re still all-time greats.
  • Sammy Sosa’s case rests disproportionately on homers and, as everyone knows, PEDs = instant dingers, so no, he’s not gonna cut it.

And so on.

As I said, I’m glad that the strict moral test — did he use or not? — is losing its hold on Hall voters. But I do not think the “did PEDs make him who he was test?” is a good approach either. Baseball writers are in no better a position to assess the physiological and performance enhancements caused by pharmaceuticals than they are to be judges of character and morality. Given the identities of players confirmed to be PED users, the old eye test implicit in these cases is famously faulty (Neifi Perez, anyone?). The idea that PEDs only affect home run totals — and not, say, the ability for a player to take the abuse of the catcher position for 21 seasons — is crude and ignorant.

I suppose it’s naive to expect voters to completely disregard PEDs in their assessment of players. It’s a bell that cannot be unrung. But while we may, thankfully, be moving away from a moral test with respect to drugs, it’s been displaced by a scientific test that is no more reasonable in practice.